

Other version: http://www.omicsonline.org/2155-6156/2155-6156-2-126.digital/2155-6156-2-126.html
![]() |
Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes |
|
Authors | ||
Published in | Journal of Diabetes and Metabolism. 2011, vol. 2, no. 4 | |
Identifiers | ||
Full text |
![]() ![]() Other version: http://www.omicsonline.org/2155-6156/2155-6156-2-126.digital/2155-6156-2-126.html |
|
Structures | ||
Citation (ISO format) | FOUQUERAY, Pascale et al. Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes. In: Journal of Diabetes and Metabolism, 2011, vol. 2, n° 4. doi: 10.4172/2155-6156.1000126 https://archive-ouverte.unige.ch/unige:47301 |